Evaluation of microsomal incubation conditions on CYP3A4-mediated metabolism of cyclosporine a by a statistical experimental design

被引:10
作者
Hermann, M [1 ]
Kase, ET [1 ]
Molden, E [1 ]
Christensen, H [1 ]
机构
[1] Univ Oslo, Sch Pharm, Dept Pharmaceut Biosci, N-0316 Oslo, Norway
关键词
microsomes; incubation conditions; experimental design; PLS; cyclosporine;
D O I
10.2174/138920006776359275
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Objective: The aim of this study was to evaluate the influence of microsomal incubation conditions on CYP3A4-mediated metabolism of cyclosporine (CsA) within the limits of previous in vitro studies by application of a statistical experimental design. The effect of changes in microsomal incubation conditions (NADPH, Mg2+, Cl-, NADPH-regenerating system and pH) on the formation of the CYP3A4 metabolites AM1 and AM9 from CsA were studied by application of a fractional factorial design. Metabolism was studied in microsomes of transfected human liver epithelial (THLE) cells specifically expressing CYP3A4. Within the conditions tested, a 3-4-fold difference in formation of CsA metabolites was observed. Formation of both AMI and AM9 was favoured by a low Mg2+ concentration (0.5 mM) and no addition of Cl- to the incubation matrix. However, while a high NADPH concentration (1.75 mM) was the single most important factor for the formation of AM1, changes in NADPH concentration between 0.25 and 1.75 mM had no influence on AM9 formation. Formation of the two metabolites also differed in their influence by pH changes, as a change in pH from 7.2 to 7.5 significantly increased the formation of AM9, while fort-nation of AM1 was unaffected by this change. The present study showed that relatively small changes in the incubation matrix had a significant influence on the microsomal CYP3A4-mediated metabolism of CsA. Systematic studies on microsomal incubation conditions could be a key to improve metabolic in vitro-in vivo extrapolations in drug development.
引用
收藏
页码:265 / 271
页数:7
相关论文
共 30 条
[1]   CONFORMATIONAL POLYMORPHISM OF CYCLOSPORINE-A [J].
ALTSCHUH, D ;
BRAUN, W ;
KALLEN, J ;
MIKOL, V ;
SPITZFADEN, C ;
THIERRY, LC ;
VIX, O ;
WALKINSHAW, MD ;
WUTHRICH, K .
STRUCTURE, 1994, 2 (10) :963-972
[2]  
AOYAMA T, 1989, J BIOL CHEM, V264, P10388
[3]   Qualitative and quantitative assessment of drug-drug interaction potential in man, based on Ki, IC50 and inhibitor concentration [J].
Blanchard, N ;
Richert, L ;
Coassolo, P ;
Lavé, T .
CURRENT DRUG METABOLISM, 2004, 5 (02) :147-156
[4]   Usefulness of statistic experimental designs in enzymology: Example with recombinant hCYP3A4 and 1A2 [J].
Bournique, B ;
Petry, M ;
Gonsset, G .
ANALYTICAL BIOCHEMISTRY, 1999, 276 (01) :18-26
[5]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[6]   In vitro metabolism of cyclosporine A by human kidney CYP3A5 [J].
Dai, Y ;
Iwanaga, K ;
Lin, YS ;
Hebert, MF ;
Davis, CL ;
Huang, WL ;
Kharasch, ED ;
Thummel, KE .
BIOCHEMICAL PHARMACOLOGY, 2004, 68 (09) :1889-1902
[7]  
ESBESEN K, 2000, MULTIVARIATE DATA AN
[8]   EXPRESSION OF CYTOCHROME-P450 2D6 IN ESCHERICHIA-COLI, PURIFICATION, AND SPECTRAL AND CATALYTIC CHARACTERIZATION [J].
GILLAM, EMJ ;
GUO, ZY ;
MARTIN, MV ;
JENKINS, CM ;
GUENGERICH, FP .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1995, 319 (02) :540-550
[9]  
Graham J., 1984, CENTRIFUGATION PRACT, P161
[10]   Identification of three key residues in substrate recognition site 5 of human cytochrome P450 3A4 by cassette and site-directed mutagenesis [J].
He, YA ;
He, YQ ;
Szklarz, GD ;
Halpert, JR .
BIOCHEMISTRY, 1997, 36 (29) :8831-8839